Oct 12, 2021 / 03:00PM GMT
Ed Arce - H.C. Wainwright & Co. - Analyst
Hello, and welcome to the fifth annual H.C. Wainwright NASH investor conference. My name is Ed Arce; I am one of the senior biotech analysts here at H.C. Wainwright. And I am very pleased to have with us our next presenting company, Galectin Therapeutics. And representing the Company is the Chief Medical Officer, Dr. Pol Boudes. Paul, welcome to the conference.
Pol Boudes - Galectin Therapeutics Inc. - Chief Medical Officer
Ed, thank you very much. Thanks for the invitation and it's always a pleasure to be here. And I already learned new things this morning, which is always very nice. You think you hear talks and -- but there is always something new going on in the world of NASH. So, that's great.
Questions and Answers:
Ed Arce - H.C. Wainwright & Co. - AnalystGreat. I'm glad to have you with us. So let's jump right in. First question, just sort of to set the stage for perhaps those investors who may not be as familiar with the Company, is to discuss what is
Trustpilot
